CVD Masterclass: Chapter 3- Overview of Hypertension

Select Content Type
Resources
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Pharmacology
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
CVD
Detail Image
CVD
Book Detail
Publication Date
Actions
Download in App
IS_Ebsco
false
Description

The global burden of hypertension is an estimated 1.13 billion people, with 2/3rds of the hypertensive population reported to be from low- and middle-income countries. Of this, Africa has the highest prevalence, around 27%, with Nigeria being a major contributor to the increasing incidence of hypertension. One of the primary reasons for rise in hypertension is the general unawareness of the condition and its related complications. Hence, with respect to the African continent, let’s discuss the various patient-related barriers to hypertension control in the Nigerian population and innovations that can empower patients and communities to take more responsibility in control and management of hypertension.

The global burden of hypertension is an estimated 1.13 billion people, with 2/3rds of the hypertensive population reported to be from low- and middle-income countries. Of this, Africa has the highest prevalence, around 27%, with Nigeria being a major contributor to the increasing incidence of hypertension. One of the primary reasons for rise in hypertension is the general unawareness of the condition and its related complications. Hence, with respect to the African continent, let’s discuss the various patient-related barriers to hypertension control in the Nigerian population and innovations that can empower patients and communities to take more responsibility in control and management of hypertension.

Published Date